# Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

> **NCT02117115** · EARLY_PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 21 (actual)

## Conditions studied

- Myelodysplastic Syndromes
- Leukemia, Myeloid, Acute
- Leukemia, Myelogenous, Chronic
- Multiple Myeloma

## Interventions

- **RADIATION:** Dynamic contrast-enhanced computed tomography
- **DRUG:** Ioversol

## Key facts

- **NCT ID:** NCT02117115
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-10
- **Final completion:** 2015-05
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2015-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02117115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02117115, "Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02117115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*